Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000488140 | SCV000574915 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | WNK1: BP4 |
Labcorp Genetics |
RCV001085123 | SCV001014336 | likely benign | Neuropathy, hereditary sensory and autonomic, type 2A; Pseudohypoaldosteronism type 2C | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001333783 | SCV001526463 | uncertain significance | Neuropathy, hereditary sensory and autonomic, type 2A | 2018-11-19 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV002446950 | SCV002734528 | likely benign | Inborn genetic diseases | 2021-11-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000488140 | SCV004564792 | likely benign | not provided | 2023-09-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003902736 | SCV004718942 | likely benign | WNK1-related disorder | 2023-06-13 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |